Trial NCT00096265

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2009-00720
Secondary IDs: CDR0000389490 NCI-2009-00720 RTOG 0320 RTOG-0320 U10CA021661

Last trial update was posted on 2018-03-09

MeSH Interventions

Erlotinib Hydrochloride Temozolomide

MeSH Conditions

Brain Neoplasms Carcinoma, Non-Small-Cell Lung Lung Neoplasms Neoplasms

Other Conditions

Metastatic Malignant Neoplasm in the Brain Recurrent Non-Small Cell Lung Carcinoma Stage IV Non-Small Cell Lung Cancer AJCC v7

Stopping Reasons

N/A

Limitations And Caveats

This study stopped accrual early due to unmet targeted accrual goals with 126 subjects accrued out of 381 planned.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID